Starting Dose of Propranolol for Migraine Prophylaxis
Start propranolol at 80 mg once daily for migraine prevention in healthy adults. This is the established initial dose supported by multiple guidelines and FDA labeling 1, 2, 1, 3.
Dosing Algorithm
Initial Dosing
- Begin with 80 mg once daily (using extended-release formulation) 3
- If using immediate-release formulation, divide the total daily dose into 2-3 administrations 1
Dose Titration
- Increase gradually at 3-7 day intervals if initial response is inadequate 3
- Target maintenance dose: 120-160 mg daily for most patients 1, 2, 1
- Maximum effective dose: 240 mg daily 1
- Doses above 320 mg daily have not been established as safe or effective 3
Clinical Evidence Supporting This Approach
The evidence consistently demonstrates propranolol's efficacy at 80-240 mg/day across multiple high-quality guidelines 1. The 2002 U.S. Headache Consortium guidelines, endorsed by both the American Academy of Neurology and American Academy of Family Physicians, established propranolol as a first-line agent with strong evidence at this dosing range 1, 2, 1.
Research supports starting low: A 1989 study demonstrated that approximately 73.5% of patients responded to low doses (around 1 mg/kg/day, roughly 60-80 mg for average adults), with only one-third requiring higher doses 4. This supports the conservative starting approach of 80 mg daily.
The most recent 2024 meta-analysis confirmed moderate certainty evidence that propranolol reduces monthly migraine days by 1.27 days compared to placebo, with a 65% increased likelihood of achieving 50% or greater reduction in migraine frequency 5.
Important Clinical Considerations
Timeframe for Assessment
- Allow 2-3 months at therapeutic dose before determining efficacy 2
- Clinical benefits may not become apparent for several weeks 3
- If no response after 4-6 weeks at maximum tolerated dose, discontinue 3
Common Adverse Effects
Expect fatigue, depression, nausea, dizziness, and insomnia 1. These are generally well-tolerated and rarely cause discontinuation. High certainty evidence shows propranolol increases discontinuation due to adverse events by only 2% compared to placebo 5.
Critical Pitfalls to Avoid
- Do not use beta-blockers with intrinsic sympathomimetic activity (acebutolol, alprenolol, oxprenolol, pindolol) - these are ineffective for migraine 1
- Do not abruptly discontinue - taper gradually over several weeks to avoid rebound 2, 3
- Screen for contraindications: heart block, asthma, severe bradycardia, hypoglycemia risk 6
When to Choose Propranolol Over Alternatives
Propranolol is particularly effective for migraine without comorbid tension-type headache 1. If the patient has mixed migraine and tension-type headache, amitriptyline may be superior 1.
The 2025 American College of Physicians guideline recommends propranolol (or metoprolol) as a first-line option before more expensive CGRP-targeted therapies, based on cost-effectiveness and similar efficacy 7. The 2024 VA/DoD guideline gives propranolol a weak recommendation, acknowledging its established role despite newer alternatives 8.